Search research articles
Contact Us
Filters
Showing results (11-20 of 459) with videos related to
Page
of 46
Sort By:
Current Hematologic Malignancy Reports
|
January 25, 2021
A New Target for Hodgkin Lymphoma - Camidanlumab Tesirine
Narendranath Epperla, Mehdi Hamadani
Hematology. American Society of Hematology. Education Program
|
December 10, 2021
Double-refractory Hodgkin lymphoma: tackling relapse after brentuximab vedotin and checkpoint inhibitors
Narendranath Epperla, Mehdi Hamadani
Current Hematologic Malignancy Reports
|
November 9, 2024
Contemporary Updates in the Prevention and Treatment of Graft-Versus-Host Disease
Sameem Abedin, Mehdi Hamadani
Hematology/Oncology and Stem Cell Therapy
|
June 21, 2017
Hematopoietic cell transplantation for diffuse large B-cell and follicular lymphoma: Current controversies and advances
Narendranath Epperla, Mehdi Hamadani
Blood
|
September 19, 2009
Reduced-intensity conditioning allogeneic stem cell transplantation in HIV patients with hematologic malignancies: yes, we can
Mehdi Hamadani, Steven M Devine
Journal of Oncology Practice
|
December 13, 2017
Allogeneic Transplantation for Follicular Lymphoma: Does One Size Fit All?
Mehdi Hamadani, Mary M Horowitz
Hematological Oncology
|
August 1, 2009
Remission induction, consolidation and novel agents in development for adults with acute myeloid leukaemia
Mehdi Hamadani, Farrukh T Awan
Clinical Advances in Hematology & Oncology : H&O
|
May 23, 2008
Review: isolated skeletal involvement in hairy cell leukemia
Mehdi Hamadani, Eric H Kraut
Hematological Oncology
|
October 10, 2012
Rituximab maintenance versus retreatment in follicular lymphoma
Amruth R Palla, Mehdi Hamadani
Expert Opinion on Investigational Drugs
|
April 16, 2020
Ruxolitinib: a potential treatment for corticosteroid refractory acute graft-versus-host disease
Sameem M Abedin, Mehdi Hamadani
Page
of 46
Search research articles
Search
Showing results (11-20 of 459) with videos related to
Sort By:
Page
of 46
Current Hematologic Malignancy Reports
|
January 25, 2021
A New Target for Hodgkin Lymphoma - Camidanlumab Tesirine
Narendranath Epperla, Mehdi Hamadani
Hematology. American Society of Hematology. Education Program
|
December 10, 2021
Double-refractory Hodgkin lymphoma: tackling relapse after brentuximab vedotin and checkpoint inhibitors
Narendranath Epperla, Mehdi Hamadani
Current Hematologic Malignancy Reports
|
November 9, 2024
Contemporary Updates in the Prevention and Treatment of Graft-Versus-Host Disease
Sameem Abedin, Mehdi Hamadani
Hematology/Oncology and Stem Cell Therapy
|
June 21, 2017
Hematopoietic cell transplantation for diffuse large B-cell and follicular lymphoma: Current controversies and advances
Narendranath Epperla, Mehdi Hamadani
Blood
|
September 19, 2009
Reduced-intensity conditioning allogeneic stem cell transplantation in HIV patients with hematologic malignancies: yes, we can
Mehdi Hamadani, Steven M Devine
Journal of Oncology Practice
|
December 13, 2017
Allogeneic Transplantation for Follicular Lymphoma: Does One Size Fit All?
Mehdi Hamadani, Mary M Horowitz
Hematological Oncology
|
August 1, 2009
Remission induction, consolidation and novel agents in development for adults with acute myeloid leukaemia
Mehdi Hamadani, Farrukh T Awan
Clinical Advances in Hematology & Oncology : H&O
|
May 23, 2008
Review: isolated skeletal involvement in hairy cell leukemia
Mehdi Hamadani, Eric H Kraut
Hematological Oncology
|
October 10, 2012
Rituximab maintenance versus retreatment in follicular lymphoma
Amruth R Palla, Mehdi Hamadani
Expert Opinion on Investigational Drugs
|
April 16, 2020
Ruxolitinib: a potential treatment for corticosteroid refractory acute graft-versus-host disease
Sameem M Abedin, Mehdi Hamadani
Page
of 46